Inhibitory Potency of Selected Therapeutic Bioactive Molecules of Standardized Terminalia arjuna (Roxb.) Extract on CYP3A4 and CYP2D6: Exploring Possible Herb-Drug Interactions.

A number of significant herbal drug interactions have their origins in the alteration of cytochrome P450 (CYP) activity by various phytochemicals. In the present study, inhibition potential of Terminalia arjuna extracts and its constituent gallic acid (GA) and ellagic acid (EA) to cause herb-drug interactions through rat liver cytochrome enzymes, CYP3A4, and CYP2D6 was evaluated, a rapid RP-HPLC method was developed for quantitative estimation of GA and EA in the extract. In vitro safety of the extract and active components were evaluated through CYP450 inhibition method using pooled rat microsomes and high throughput fluorometric assay with CYP3A4 and CYP2D6. The binding mode and the molecular interaction of GA and EA within the CYP3A4 and CYP2D6 active site were demonstrated using an in-silico docking studies. From CYP450-CO Complex assay, the inhibitory potential of T. arjuna standardized extract (31.02 ± 2.24%), was found to be less than positive control. In high throughput i¬‚uorometric assay, T. arjuna extracts exhibited higher IC50 values (48.06 ± 1.14-57.89 ± 2.15 μg/mL) compared to positive inhibitors and lower than GA (66.54 ± 1.04-83.84 ± 1.06 μg/mL), EA (69.47 ± 1.18-102.69 ± 2.87 μg/mL) on CYP3A4 and CYP2D6. Based on the inhibitory potential of test samples, it can be concluded that T. arjuna and its standardized bioactive molecules could produce weak interaction potential when co-administered with conventional medicines.

[1]  A. Agrawal,et al.  Pharmacogenetic Comprised Prospect on Cytochrome P450 Facilitated Drug Interactions , 2013 .

[2]  O. G. Nilsen,et al.  In vitro Inhibition of CYP3A4 by the Multiherbal Commercial Product Sambucus Force and its Main Constituents Echinacea purpurea and Sambucus nigra , 2012, Phytotherapy research : PTR.

[3]  P. Mukherjee,et al.  Botanicals as medicinal food and their effects on drug metabolizing enzymes. , 2011, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[4]  P. Mukherjee,et al.  Exploring the Possible Metabolism Mediated Interaction of Glycyrrhiza glabra Extract with CYP3A4 and CYP2D6 , 2011, Phytotherapy research : PTR.

[5]  P. Mukherjee,et al.  Cytochrome P450 inhibitory potential of Triphala--a Rasayana from Ayurveda. , 2011, Journal of ethnopharmacology.

[6]  O. Pelkonen,et al.  Rapid screening of commercially available herbal products for the inhibition of major human hepatic cytochrome P450 enzymes using the N-in-one cocktail , 2010, Xenobiotica; the fate of foreign compounds in biological systems.

[7]  A. Kortenkamp,et al.  Metabolomic profiling of liquid Echinacea medicinal products with in vitro inhibitory effects on cytochrome P450 3A4 (CYP3A4). , 2010, Planta medica.

[8]  Hua Yang,et al.  Inhibition of cytochrome P450 enzymes by rhein in rat liver microsomes , 2009, Phytotherapy research : PTR.

[9]  D. Carrier,et al.  Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea. , 2008, Molecular nutrition & food research.

[10]  Stephen Fowler,et al.  In Vitro Evaluation of Reversible and Irreversible Cytochrome P450 Inhibition: Current Status on Methodologies and their Utility for Predicting Drug–Drug Interactions , 2008, The AAPS Journal.

[11]  A. Kortenkamp,et al.  Herbal extracts used for upper respiratory tract infections: are there clinically relevant interactions with the cytochrome P450 enzyme system? , 2008, Planta medica.

[12]  Shufeng Zhou,et al.  Clinically Important Drug Interactions Potentially Involving Mechanism-based Inhibition of Cytochrome P450 3A4 and the Role of Therapeutic Drug Monitoring , 2007, Therapeutic drug monitoring.

[13]  Richard A. Friesner,et al.  Flexible ligand docking with Glide. , 2007, Current protocols in bioinformatics.

[14]  Jane Qiu,et al.  China plans to modernize traditional medicine , 2007, Nature.

[15]  H. Iwata,et al.  Mechanism-based inhibition of CYP3A4 and CYP2D6 by Indonesian medicinal plants. , 2006, Journal of ethnopharmacology.

[16]  S. Kadota,et al.  Cytochrome P450 2D6 (CYP2D6) inhibitory constituents of Catharanthus roseus. , 2005, Biological & pharmaceutical bulletin.

[17]  P. Frohberg,et al.  A microtiterplate-based screening assay to assess diverse effects on cytochrome P450 enzyme activities in primary rat hepatocytes by various compounds. , 2005, Assay and drug development technologies.

[18]  H. Cai,et al.  Induction and inhibition of cytochromes P450 by the St. John's wort constituent hyperforin in human hepatocyte cultures. , 2004, Drug metabolism and disposition: the biological fate of chemicals.

[19]  A. D. Rodrigues,et al.  Mechanism-based inhibition of human liver microsomal cytochrome P450 1A2 by zileuton, a 5-lipoxygenase inhibitor. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[20]  Min Huang,et al.  Interactions of Herbs with Cytochrome P450 , 2003, Drug metabolism reviews.

[21]  S. Singhal,et al.  Antioxidant and hypocholesterolaemic effects of Terminalia arjuna tree-bark powder: a randomised placebo-controlled trial. , 2001, The Journal of the Association of Physicians of India.

[22]  S. D. Turner,et al.  Substrate-dependent modulation of CYP3A4 catalytic activity: analysis of 27 test compounds with four fluorometric substrates. , 2000, Drug metabolism and disposition: the biological fate of chemicals.

[23]  M. Harkey,et al.  Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity. , 1999, Life sciences.

[24]  S. Dwivedi,et al.  Beneficial effects of Terminalia arjuna in coronary artery disease. , 1997, Indian heart journal.

[25]  A. Bharani,et al.  Salutary effect of Terminalia Arjuna in patients with severe refractory heart failure. , 1995, International journal of cardiology.

[26]  S. Dwivedi,et al.  Antianginal and cardioprotective effects of Terminalia arjuna, an indigenous drug, in coronary artery disease. , 1994, The Journal of the Association of Physicians of India.

[27]  S. Verma,et al.  Current and future status of herbal medicines , 2008 .

[28]  Y. Kohno,et al.  Application of microtiter plate assay to evaluate inhibitory effects of various compounds on nine cytochrome P450 isoforms and to estimate their inhibition patterns. , 2002, Drug metabolism and pharmacokinetics.

[29]  HighWire Press,et al.  Drug metabolism and disposition : the biological fate of chemicals. , 1973 .